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Introduction
Tuberculosis (TB) is a major public health disease, affect-
ing one third of the world’s population and killing
approximately two million people yearly. The emergence
of resistance to anti-tuberculosis drugs, particularly MDR-
TB.
Objectives
To determine prevalence of multidrug-resistant tuberculo-
sis (MDR-TB) and associated risk factors among adult
(≥18 years) HIV positive patients registered at Mpilo
Opportunistic Infection (OI) clinic. To assess the associa-
tion of CD4 count and MDR-TB.
Methods
A health facility based cross-sectional study was carried
out at Mpilo OI Clinic between 01 March and 31 July
2012. Convenience sampling was used to recruit 275 adult
HIV positive patients into the study on a daily basis. A sin-
gle sample for MDR-TB was collected from each one of
these participants. A total of 275 sputum and aspirate
(Bone marrow, Aspirates, pus Cerebrospinal fluid) samples
were collected and cultured for MDR-TB using both the
Liquid using BACTEC Mycobacterium Growth Indicator
Tube 960 (MGIT) and the Conventional Solid Lowenstein
Jensen (LJ) culture methods. Whole blood for CD4 count
was collected from each participant and tested using BD
FACS Calibur Flow Cytometry CD4 count machine. Logis-
tic regression was used to determine predictors of MDR-
TB prevalence.
Results
The prevalence of MDR-TB was 2.6% among adult HIV
patients registered at Mpilo OI Clinic and attended the
clinic between 01 March and 31July 2012. In the multi-
variate analysis, MDR-TB prevalence was associated with
CD4 count (OR 0.14 p=0.043).
Conclusion
A prevalence of 2.6% of MDR-TB among HIV positive
patients was found. This is very high considering this high
MDR-TB risk group. A CD4 count of >200 cells/ul was
found to be protective of high MDR-TB prevalence.
Targeted interventions of MDR-TB are necessary to
reduce incident MDR-TB cases among HIV positive
patients. Increased MDR-TB case finding through culture
and Drug Susceptibility testing before initiation of First
line drugs is necessary to reduce mistreatment. Infection
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